Kestra Private Wealth Services LLC Purchases 1,206 Shares of Stryker Co. (NYSE:SYK)

Kestra Private Wealth Services LLC increased its position in shares of Stryker Co. (NYSE:SYK) by 6.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,064 shares of the medical technology company’s stock after acquiring an additional 1,206 shares during the period. Kestra Private Wealth Services LLC’s holdings in Stryker were worth $6,864,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Howland Capital Management LLC raised its stake in Stryker by 9.5% during the fourth quarter. Howland Capital Management LLC now owns 87,461 shares of the medical technology company’s stock worth $31,564,000 after acquiring an additional 7,611 shares in the last quarter. Birch Hill Investment Advisors LLC grew its holdings in shares of Stryker by 29.5% during the 4th quarter. Birch Hill Investment Advisors LLC now owns 795 shares of the medical technology company’s stock valued at $286,000 after purchasing an additional 181 shares during the last quarter. Entropy Technologies LP acquired a new position in Stryker during the 4th quarter worth approximately $236,000. Empowered Funds LLC lifted its stake in Stryker by 17.5% in the 4th quarter. Empowered Funds LLC now owns 7,644 shares of the medical technology company’s stock valued at $2,752,000 after purchasing an additional 1,140 shares during the last quarter. Finally, Kingsview Wealth Management LLC boosted its position in Stryker by 1.4% in the fourth quarter. Kingsview Wealth Management LLC now owns 14,318 shares of the medical technology company’s stock valued at $5,155,000 after buying an additional 200 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of research reports. Piper Sandler reiterated an “overweight” rating and issued a $420.00 price target (up from $380.00) on shares of Stryker in a research note on Wednesday, October 30th. Truist Financial increased their target price on Stryker from $409.00 to $413.00 and gave the company a “hold” rating in a research report on Thursday, January 30th. Evercore ISI boosted their price target on Stryker from $380.00 to $384.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Wells Fargo & Company raised their price objective on shares of Stryker from $427.00 to $435.00 and gave the company an “overweight” rating in a report on Wednesday, January 29th. Finally, Citigroup boosted their target price on shares of Stryker from $411.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $419.37.

Stryker Stock Down 1.2 %

Shares of NYSE:SYK opened at $391.42 on Monday. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The business’s 50-day moving average is $377.23 and its 200-day moving average is $364.97. The company has a market capitalization of $149.22 billion, a price-to-earnings ratio of 50.44, a P/E/G ratio of 2.98 and a beta of 0.96.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period last year, the firm earned $3.46 EPS. Equities research analysts predict that Stryker Co. will post 13.49 earnings per share for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s payout ratio is 43.30%.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 201,392 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the sale, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.